For example, when AR transcriptional activity has been characterized in primary prostate tumors by the expression pattern of the AR gene itself as well as the 20 previously described AR target genes, tumors with SPOP or FOXA1 mutations have the highest AR transcriptional activity (47). This evidence concerns the gene FOXA1 and prostate neoplasm.